← All stocks

Pyxis Oncology, Inc.

PYXS No buying or selling
CIK 0001782223 #3722 in the set updated 20 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

4 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Connealy Pamela Ann
CFO & COO
1,199,143
$3.67M
+8.0%
Wadhane Jitendra
Prin Fin & Acct Officer
512,882
$1.57M
+27.1%
HUMPHREY RACHEL
Director
81,309
$248.81K
−16.0%
Dupont Jakob
Director
38,741
$118.55K
0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 12 Oct 2021